Sudeep Pharma has announced its Initial Public Offering (IPO) and is expected to be listed soon. The IPO opened on Nov 21, 2025 and will close on Nov 25, 2025. The price band has been set at ₹563.00-593.00.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1.16 | 5.14 | 8.36 | 2.63 | -0.15 | 21.01 | 28.71 |
| Divi's Laboratories | -0.75 | -1.89 | 7.21 | -1.37 | 8.12 | 25.54 | 13.25 |
| Torrent Pharmaceuticals | -2.88 | 3.63 | 2.03 | 13.15 | 19.97 | 31.81 | 23.32 |
| Cipla | -0.19 | -8.08 | -3.99 | 3.16 | 4.35 | 11.46 | 15.63 |
| Dr. Reddy's Laboratories | 0.21 | -3.11 | -2.19 | 1.95 | 4.45 | 12.8 | 5.97 |
| Zydus Lifesciences | -1.74 | -7.15 | -5.86 | 4.31 | -1.7 | 32.7 | 16.86 |
| Lupin | -1.19 | 4.56 | 3.48 | 1.74 | -0.6 | 41.23 | 18.24 |
| Mankind Pharma | -1.22 | -8.43 | -13.87 | -11.53 | -12.47 | 16.34 | 9.5 |
| Aurobindo Pharma | -1.21 | 9.74 | 16.01 | 0.3 | -1.01 | 37.57 | 7.7 |
| Alkem Laboratories | -0.39 | 2.75 | 5.13 | 6.07 | 1.7 | 22.72 | 16.3 |
| Abbott India | 0.84 | -2.21 | -9.35 | -5.89 | 9.11 | 14.73 | 14.03 |
| Laurus Labs | -1.19 | 6.84 | 10.92 | 65.33 | 101.8 | 29.49 | 28.4 |
| Glenmark Pharmaceuticals | -0.93 | 1.22 | -3.24 | 30.41 | 28.07 | 65.85 | 31.27 |
| Biocon | -3.89 | 7.93 | 10.45 | 16 | 22.3 | 11.45 | -1.21 |
| GlaxoSmithKline Pharmaceuticals | 1.19 | -9.05 | -9.76 | -15.92 | 5.88 | 24.23 | 10.48 |
| Ipca Laboratories | -2.8 | 12.25 | 5.82 | -2.25 | -8.6 | 18.31 | 6.11 |
| Anthem Biosciences | -4.63 | -12.76 | -23.5 | -11.35 | -11.35 | -3.94 | -2.38 |
| Ajanta Pharma | -0.5 | 2.58 | -5.49 | -4.82 | -14.76 | 26.88 | 19.76 |
| Gland Pharma | -0.69 | -5.47 | -6.56 | 15.66 | 1.7 | 1.93 | -0.02 |
Sudeep Pharma Ltd. is a Public Limited Listed company incorporated on 21/12/1989 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24231GJ1989PLC013141 and registration number is 013141. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 356.73 Cr. and Equity Capital is Rs. 9.72 Cr. for the Year ended 31/03/2025.